”) would like to inform you that, in accordance with the resolutions of the Board of Directors’ Meeting No. 10/2017 held on October 30, 2017 and the Extraordinary General Meeting of Shareholders’ No.1/2018

บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2 Tambon Thachin,Amphur Muangsamutsakhon,Samutsakhon 74000,Thailand. - 1 - No

1.97 percent Value of Securities Issued Not qualified - Note: 1. The Company’s total asset from the audited consolidated financial statements ending 30 June 2019 5. Opinion of the Board of Directors and

Microsoft Word - MD_A_Q3_2019_EN 1 GLOCON.061/2019 November 11th, 2019 Subject Management’s analysis for the 3rd quarter of 2019 Attn. The President The Stock Exchange of Thailand Management’s

1 / 4 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS • Explanation and analysis of financial performance for the year ended 31 December 2019 • Explanation and

as follows: 1) Transaction Date On April 10, 2019, the Company enters into the Agreement to Share Sale and Purchase Agreement to sell shares of Mo Chit Land in the amount of 29,550,000 shares or

and accepted between the buyer and the seller. After purchasing shares, PAF will become a subsidiary of the company or holds share 99.50% of PAF’s registered capital, with the following details : 1

issuance of new securities as consideration. — Remarks: 1. In calculating the transaction value, the Company used the figures based on the latest reviewed Consolidated Financial Statement ending 30 June 2017

transaction value, from the Consolidated Financial Statement of the Company for the period ending 30 September 2017 which was reviewed by the certified public accountant. In this regard, there were no other

[COMPANY NAME] Ref.: EFORL IR007/2020 March 4, 2020 Subject: Management Discussion and Analysis Yearly Ending 31 December, 2019 To President The Stock Exchange of Thailand 1. Overview financial